Total Assets
Rate Of Return$Recursion Pharmaceuticals(RXRX.US) position has been established, waiting for the FDA communication on the REC-4881 pipeline in June. If the FDA recognizes the data and provides support, that will be the beginning of a double.
This price level for RXRX is like buying a lottery ticket. For higher certainty, it is recommended to wait for the confirmation from the FDA communication in June before entering a right-side trade.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
